Samsung Biologics to build 256,000-liter plant 4
Samsung Biologics CEO Kim Tae-han announces the company's plan to build plant No.4 in Incheon, during an online press conference on Tuesday. Courtesy of Samsung BiologicsBy Nam Hyun-wooSamsung Biologics announced its plans to build a 256,000-liter plant in Incheon, which will be the world's largest single plant producing biologic drugs. “With the new plant No.4, Samsung Biologics will shatter its own record of having the largest biologic plant in the world,” Kim Tae-han, CEO of the contract drug manufacturer, said Tuesday during an online press conference. “When plant No.4 is completed, our manufacturing complex will have a combined capacity of 650,000 liters, which accounts for 30 percent of the global contract manufacturing facilities. Furthermore, we also have a plan to secure 330,000 square meters of land in Incheon to build another biologics complex in the future.”Samsung Biologics currently has three plants, and the third one is the largest single drug manufacturing plant in the world with an 180,000-liter capacity. For plant No. 4, Kim said the company
Aug 11, 2020By Nam Hyun-woo